The aim of this study was to investigate the effects of Aornia melanocarpa anthocyanin (AMA) on symptoms of metabolic syndrome in obese mouse. AMA can reduce weight. Blood glucose and lipid metabolism were significantly improved, and so as hepatic lipid metabolism. This suggesting AMA is a strong indication of improved glucoselipid metabolism and weight. Moreover, both morphologic and histological detections indicated that AMA significantly reversed obsity induced hepatic steatosis and liver injury. Furthermore, AMA significantly ameliorated inflammatory cytokines including both IL-6 and TNF-α in liver and fatty tissue. Moreover, insulin receptor (IR), p-IRS and p-AKT that associated proteins about glucose-lipid metabolism signaling pathway were markedly up-regulated at protein levels by AMA. Our results demonstrate that Aornia melanocarpa anthocyanin treatment can alleviate obsity and metabolic syndrome. The beneficial effects of AMA are associated with improved glucose-lipid metabolism and reduced levels of inflammatory cytokines.
INTRODUCTION
The obesity epidemic is a global issue and shows no signs of abating.
1,2 while the cause of this epidemic remains unclear. 3, 4 And Obesity is the main cause of metabolic disorders. 5 Marketing practices of energydense foods and institutionally-driven declines in physical activity are the alleged perpetrators for the epidemic, despite a lack of solid evidence to demonstrate their causal role. [6] [7] [8] [9] [10] Considering the role of such putative etiological factors of obesity may lead to comprehensive, cause specific, and effective strategies for prevention and treatment of this global epidemic. Fruits and vegetables have abundance and variety of bioactive compounds present. As an alternative to pharmaceutical medications, consumption of diets rich in natural bioactive components and their contribution to improving metabolic disorders and obese has been a subject of considerable interest to researchers. Many published cohort studies suggest that high intakes of flavonoids may be associated with a decreased risk of metabolic disorders. [11] [12] [13] [14] Aronia Melanocarpa, also called black chokeberry, is a member of the Rosaceae family. Shrubs of the aronia genus are native North American plants that have been traditionally used in Native American medicine, for example in the treatment of colds 15, 16 The aronia plant has become popular in recent years due to its berries having a high content of anthocyanins with antioxidant activity. Aronia products are well received as nutritional supplements, and the berries are also used as an ingredient for juices, wines, jams, and as a source of natural food colorants. 16 In recent years, black chokeberries have gained popularity due to their high content of polyphenols with antioxidant activity. In fact, they possess the highest anti oxidant activity among berries and other fruits investigated so far as measured with the oxygen radical scavenging capacity (ORAC) assay. 16, 17 The Aronia berries contain high levels of flavonoids, mostly anthocyanins and proanthocyanidins. The formation of free radicals is strongly associated with lipid peroxidation and has also been implicated in the development of a variety of diseases, including cellular aging, mutagenesis, inflammation, carcinogenesis, coronary heart disease and diabetes. Anthocyanins are a group of abundant and widely consumed flavonoid constituents possessing a characteristic C3-C6-C3 carbon structure that exists in many fruit-and vegetable-based food products. Their intake has been estimated to be up to 9-fold higher than that of other dietary flavonoids. Our preliminary work has focused on identification of Aornia melanocarpa anthocyanin (AMA) and the antioxidant properties, which included anti-lipid peroxidation capability, and superoxide anion radical-scavenging activity, hydroxyl radical-scavenging activity. The results of the study were similar to those of other scholars. 18, 19 We detected AMA containing cyanidin 3-galactoside, cyanidin 3-glucoside, cyanidin 3-arabinoside and cyanidin 3-xyloside. To continue the previous study, the current study was aimed at demonstrating the therapeutic effect of anthocyanins from Aronia fruits against metabolic disorders in obese mouse model, and further addressing its potential mechanisms. The results suggested that AMA could offer a promising source of agent that may have the potential to be used as food health products.
MATERIALS AND METHODS

Reagents and diets:
Aronia Melanocarpa fruit was provided by Liaoning Academy of Forestry (Shenyang, China), and the Aronia fruits polyphones was extract by Liaoning University (Shenyang, China). All the chemicals used were of analytical grade. The high-fat diet (HFD; 50% energy as fat, 20% protein, 30% carbohydrate) and the normal-fat diet (NFD; 10% fat, 20% protein, 70% carbohydrate). Animal care and experimental protocol: All protocols in this study were performed in accordance with the National Institutes of Health regulations for the care and use of animals in research. Five weeks KM mice (23-27 g, Benxi Changsheng Laboratory Animal Technology Co., Ltd) were maintained at a 12:12 h light: dark cycle, and given water ad libitum. Animals were housed in cages individually in an environmentally controlled room at 21 ± 2.0°C and 50% ± 5% humidity. Establishment of mice obesitymodel and anthocyanins supplementation: After one week of adaptation, female mice (6 weeks of age) were randomly divided into a normal-fat diet (NFD) group (n=10) and 4 high-fat diet (HFD) groups (n=10 ¥ 3) by weight and fed for 8 weeks, respectively. During this period, 3 HFD groups were fed with a HFD, a HFD+150 mg·L -1 and 300 mg·L -1 AMA, respectively. Mice in the control group (n=8) were maintained with NFD. Blood glucose, body weight and food intake were measured weekly, respectively. Sample collection: After the treatment for 8 weeks,mice were sacrificed by CO 2 inhalation followed by cervical dislocation, and blood was collected from the eyes. Serum was obtained and stored at -80°C until analysis. Tissues, including liver, kidney, spleen, visceral fat were removed, weighted and snap-frozen in liquid nitrogen, and stored immediately at -80°C. Lipid, adiponectin and insulin in serum were measured: The blood serum of mice received centrifugation to measure triglyceride (TG), total cholesterol (TC), low density lipoprotein cholesterol (LDL-C), high density lipoprotein cholesterol (HDL-C), adiponectin (ADPN) and insulin levels were measured using Kit (Nanjing Jiancheng Bioengineering Institute, China). For liver lipid measurement, we followed the manufacturer's instruction.
Liver TG,TC and lipid measurement:
To analyze hepatic lipid levels, liver tissue (50 mg) was homogenized in 1 ml 80% isopropyl alcohol. After centrifugation at 5000 g min -1 for 10 min, the supernatant was collected, and then TG, TC and lipid levels were measured using Kit (Nanjing Jiancheng Bioengineering Institute, China). For liver lipid measurement, we followed the manufacturer's instruction. Histological examination: At the time of killing, small pieces of liver were fixed immediately in 10% buffered formalin. As previously reported, 21 after paraffin embedding, 5 mm sections were deparaffinized in xylene and were rehydrated through a series of decreasing concentrations of ethanol. Sections were stained with hematoxylin and eosin (HE). Photomicrographs were taken on an Olympus BX 51 microscope (OLYMPUS Co. Ltd, Tokyo, Japan).
RNA extraction and quantitative RT-PCR:
Liver tissues (20 mg) and visceral fat (20 mg) were ground with the liquid nitrogen in RNase-free mortars, respectively. Total RNA was extracted from three individual mice per strain per diet group. The quality and quantity of RNA was determined. Quantitative real-time PCR analysis was performed using the ABI Prism 7900-HT sequence detection system (96 wells) as described. 22 The following primers were designed for mouse cytokine analysis and were synthesized: tumor necrosis factor-α (TNF-α), forward 5′-CCCTCACACTCAGATCATCTTCT-3′ and reverse 5′-GCTACGACGTGGGCTACAG-3′; IL-6, forward of 300 mg·L -1 AMA could restore the visceral fat to normal. This suggested that the metabolic disorders and visceral fat in mice may be caused by liver injury, and the liver injury is repaired by anthocyanins to reverse the disease.
Anthocyanins regulate the blood lipids and glucose of HFD-induced obesity
The fasting-state plasma triglycerides (TG), total cholesterol (TC), low density lipoprotein cholesterol (LDL-C) and high density lipoprotein cholesterol (HDL-C) levels of mice are shown in Figure 3A . HFD mice had abnormal serum lipid levels, which may be caused by the less efficient use of fat from the diet or obesty. The TG, TC and LDL-C levels of AMA treatment mice were lower significantly (P<0.001 or P<0.01) than the mice of HFD group. This may suggest that AMA improve the lipid metabolism. The HDL-C level increased significantly with increasing AMA content (P<0.05, P<0.001). The blood glucose level was reported in Figure 3B . As shown, the NFD group was in the flat below 10 mmol·L -1 , and HFD group increased rapidly in these weeks. In the 4 th week, anthocyanins groups were lower than HFD group significantlt (P<0.01). And in the 8 th week effect to achieve the best.
Anthocyanins regulate the blood insulin and ADPN of HFD-induced obesity
The fasting-state plasma insulin and adiponectin (ADPN) levels of mice were shown in Figure 4A , B. The insulin level of anthocyanins treatment was lower than HFD group (P<0.001). And AMA can induce the ADPN level (P<0.05, P<0.01), and the level of 300 mg·L -1 treatment was higher than NFD. This suggested that AMA regulates their level to reduce blood glucose and lipids.
Anthocyanins regulate the lipid levels in liver of HFD-induced obesity
At the end of the experiment period (8 weeks), the hepatic lipids, TG and TC of mice were determined, as shown in Figure 5 . AMA treatment reduced the lipids level in liver significantly compared to HFD group (150 mg·L -1 P<0.01, 300 mg·L -1 P<0.001). The treatment of 300 mg·L -1 AMA have obvious effect on TG (P<0.05) and TC (P<0.01). These results suggested that the AMA treatment might decrease the lipid production and storage in liver. This may suggest that AMA improve the lipid metabolism of hepatocyte.
5′-TAGTCCTTCCTACCCCAATTTCC-3′ and reverse 5′-TTGGTCCTTAGCCACTCCTTC-3′. Western blotting analyses: Extract the protein from each of the liver tissues. In brief, 22 the ground powder of frozen tissues was placed in RIPA cell lysis buffer (Cell Signaling Technology, USA) for 15 min on ice. After brief sonication, the cell lysate was centrifuged at 13500 rpm for 15 minutes at 4 o C. The supernatant was fractionated by electrophoresis in a 12% SDS-polyacrylamide gel and transferred to a nitrocellulose membrane. The following primary antibodies were used for immunoblotting: anti-IR, anti-p-IR, anti-p-AKT and antitubulin (Bio Basic Inc., Canada). Signals were detected by an enhanced chemiluminescence technique (Amersham Life Science, USA). Statistical analyses: One-way analysis of variance (ANOVA), followed by the post hoc test, was performed to analyze the data with SPSS software (SPSS16; Beijing Stats Data Mining, Beijing, China). Data were expressed as mean ± S.E.M., and P<0.05 was considered statistically significant.
RESULTS
Anthocyanins reducethe body weight and calorie intakeof HFD-induced obesity
All the anthocyanins treatment group mice are with glossy hair and a sensitive reflection ability and food ration. Dynamic change of body weight was measured during the 8 week feeding period. As the data shows in Figure 1A , body weight gradually increased over time of the HFD fed period, and the AMA groups showed significant reduction compared to HFD group in the 6-8 weeks. Figure 1B showed that the calorie intake (kcal/day) of all the groups. The calorie intake of obsity mice in HFD group were higher than NFD group significantly (P<0.05). Fortunately, the treatment of 300 mg·L -1 anthocyanins could reduce the calorie intake significantly (P<0.05). This shows that obesity might occur during this period because of the excessive caloric intake.
Anthocyanins improvethe organ hypertrophy and visceral fat excessof HFD-induced obesity
As the Figure 2A showed that 8 weeks of HFD feeding resulted in liver enlargement of mice significantly (P<0.01), and the treatment of 300 mg·L -1 AMA could improve the liver enlargement significantly (P<0.05). In addition, there was no obvious change in the liver and kidney during this period. As the Figure 2B showed the changes of visceral fat and liver index were similar. The visceral fat of obese mice HFD-induced was more than normal mice significantly (P<0.001), and the treatment
Anthocyanins ameliorate HFD-induced hepatic and adipose tissue inflammation
To further investigate the effect of AMA treatment on hepatic injury and metabolic disorders in HFD mice, the levels of inflammatory markers, IL-6 and TNF-α were measured in liver and fatty tissue. As the results show in Figure 6A , in the liver tissue, the levels of inflammatory markers (IL-6 and TNF-α) of NFD group mice were lower than HFD group mice significantly (P<0.001, P<0.05), and AMA can reduce the levels significantly (P<0.01). As the Figure 6B , the levels of inflammatory markers in fatty tissue was similar to liver tissue, and the effect was more obviously (P<0.01 or P<0.001). The data suggested that AMA treatment significantly decreased the elevation in hepatic and adipose inflammatory markers.
Anthocyanins reverse HFD-induced liver injury
After 8 weeks, AMA treatment, the pathological alterations of livers from different groups were firstly evaluatedby morphology and histological (HE staining) examination (Figure 7 ). Under microscopy, for NFD group, the structure of liver tissue is arranged neatly, the size of central venous is normal, and the sinuses are seen in the middle of the central venous. Moreover, the morphology of hepatocyte is clear, the membrane is intact and the nucleolus is clearly visible. The HFD group significantly induced massive hepatic steatosis and inflammatory cells infiltration, arranged hepatocytes into hierarchical disorder, swelled the cells, increased the size of the nucleus, decreased the consolidation of the boundaries of the hepatocytes, and eliminated some parts of the nucleolus. The anthocyanins groups supplementation obviously reversed the abovementioned HFD induced adverse changes.
Anthocyanins up-regulate the expression of IR, p-IR and p-AKT
As shown in Figure 8 , the protein (IR, p-IR and p-Akt) expression decreased significantly in the HFD group compared to NFD group. The HFD induced the expression decrease of IR, p-IR and p-Akt in liver, but AMA could increase significantly them. The pharmacological study showed that HFD induced insulin resistanceand anthocyanins could improve the insulin sensitivity because it can increase expression of IR, p-IR and p-AKT.
DISCUSSION
Our study was carried out to study the efficacy of Aornia melanocarpa fruit anthocyanins as treatment for metabolic disorders in obsity. Our results demonstrate that supplementation with anthocyanins significantly decreases body weight, liver index, calorie intake and visceral fat. Blood index was also improved that serum TG, TC, LDL-C, insulin and glucose were decreased significantly by anthocyanins, as well the serum ADPN and HDL-C was increased significantly. Furthermore anthocyanins significantly improves metabolic disorders, involving hepatic steatosis, inflammatory cytokines, and liver injury in mice fed with a HFD diet. Histological and biochemical analyses show that diet supplementation with anthocyanins reduced the development of hepatic steatosis and injury induced by the HFD diet. The decrease of inflammatory cells infiltration determined by histopathological analysis, and the reduction of hepatic lipids levels demonstrate that supplementation with anthocyanins reduced the fat accumulation in the liver. Anthocyanins significantly alleviated adipose and hepatic inflammation, evidenced by the reduction of HFD-induced increase of IL-6 and TNF-α mRNA expressions in liver. Activation of the insulin receptor (IR) triggers its intrinsic protein-tyrosine (Tyr) kinase activity, resulting in autophosphorylation of several IR Tyr residues and the recruitment and phosphorylation of IR substrate (IRS) proteins. 20 After Tyr phosphorylation, IRS acts as docking protein for several Src homology 2 (SH2) domain-containing molecules, including Grb2, the small adapter protein Nck, the tyrosine phosphatase Syp, phosphatidylinositol 3-kinase (PI3K), and others.
21
PI3K has a central role downstream of the IRS proteins in the activation and regulation of many insulin-induced metabolic processes. During its association with IRS, PI3K promotes the activation of Akt (PKB) that regulates multiple biological processes. The duration and extent of signals induced by insulin are tightly regulated to promote optimal insulin actions in the body, and impaired generation of these signals causes a common pathological state termed insulin resistance. This occurs in a wide variety of pathological states, including obesity, hypertension, chronic infection and cardiovascular diseases [22] [23] [24] The expression of protein IR, p-IR and p-AKT was also increased with anthocyanins, this suggested that anthocyanins can promote the operation of the insulin signaling pathway, increase insulin sensitivity, and then promote the absorption of glucose to achieve the effect of weight loss. 20, [24] [25] [26] And the treatment of anthocyanins 300 mg·L -1 had the best effect in all these groups. To the best of our knowledge, this study is the first to show the therapeutic role of anthocyanins in a HFDinduced obsity mouse model. anthocyanins are generally considered to be safe and have minimal adverse effects. Values are expressed as mean ± SEM. *p < 0.05 vs. HFD group. ** P< 0.01 vs. HFD group. *** P < 0.001 vs. HGFD group.
was observed in the acute toxicity study in mice in our preliminary study (Data are not shown). These results suggest that the beneficial effects of anthocyanins may be mediated by improved glucose-lipid metabolism. The possible beneficial effects of anthocyanins in obsity and diabetes mellitus need to be further investigated.
In conclusion, drinking fluid supplementation with anthocyanins significantly reduces the development of obesity, insulin resistance, hypercholesterolemia and hepatic steatosis in mice fed the HFD diet, which mimics many syndromes of metabolic disorders. These results suggest that the beneficial effects of anthocyanins may be mediated by improved lipid metabolism and decreased levels of inflammatory cytokines such as TNF-á and IL-6. The possible beneficial effects of anthocyanins in diabetic or pre-diabetic patients need to be further investigated. Values are expressed as mean ± SEM. *p < 0.05 vs. HFD group. ** P < 0.01 vs. HFD group. *** P < 0.001 vs. HFD group.
